Aoikai Medical

What Aoikai Medical does

Aoikai Medical Corporation (legal entity: Seiseikai Medical Corporation) operates Hasegawa Hospital, a psychiatric and mental health facility located in Mitaka City, Tokyo, founded in 1978. The hospital delivers a comprehensive continuum of psychiatric services including outpatient consultations, inpatient hospitalization with dedicated emergency psychiatric and acute treatment wards, modified Electroconvulsive Therapy (mECT) for treatment-resistant schizophrenia, psychiatric and physical rehabilitation, day care programs, home-based psychiatric visiting medical and nursing services, dental care, and on-site pharmacy services. Its primary customer segment is psychiatric patients — particularly those with treatment-resistant conditions, acute episodes, or rehabilitation needs — supplemented by referrals from other medical professionals routed through a dedicated Regional Healthcare Coordination Office (地域医療連携室).

The hospital's core technology is specialized psychiatric clinical care rather than a software or platform product, with the key differentiator being in-house mECT capability and a multi-disciplinary rehabilitation stack. It is one facility within the broader Aoikai Group (葵会グループ) network, which includes Aoi Mental Hospital, Nogawa Home, and affiliated rehabilitation centers, providing internal referral pathways and shared resources across the Tokyo metropolitan area. Operations are anchored in a single Mitaka City site with patient access supported by a free shuttle bus from Chofu Station.

The business model is a fee-for-service hospital operating entirely under Japan's national health insurance reimbursement system, with revenue generated from outpatient visits, inpatient stays, emergency psychiatric care, and ancillary services (dental, pharmacy, rehabilitation, visiting care). Pricing follows the government-established medical fee schedule (recently revised effective June 2026), with patient co-payments varying by age and income. The go-to-market motion is direct-to-patient, supplemented by referral-based acquisition through the Regional Healthcare Coordination Office and group-level channels. The company is privately held with no disclosed funding history, no M&A activity, and 101–250 employees.

Name

Aoikai Medical

Legal name

Seiseikai Medical Corporation

Website

https://hasegawa-hp.or.jp

Company type

Private

Founded year

1978

Operating status

Operating

Headcount range

101–250 employees

Short description

Aoikai Medical operates Hasegawa Hospital, a psychiatric and mental health facility in Mitaka City, Tokyo, part of the Aoikai Group (葵会グループ), providing outpatient, inpatient, emergency, mECT, and rehabilitation services under Japan's national health insurance system.

Ownership category

akta.pro rank

Product category

Psychiatric Healthcare Services

NAICS

Psychiatric and Substance Abuse Hospitals (62221), Outpatient Mental Health and Substance Abuse Centers (621420)

SIC

Services-Hospitals (8060)

akta.pro primary industry

Inpatient Psychiatric Hospitals (HLAFAHAH)

akta.pro secondary industries

Inpatient Psychiatric Hospitals & Units (HLAFACAB), Behavioral Health Skilled Home Health (Psychiatric Nursing) (HSABACAM)

Keywords

• Psychiatric hospital services
• Mental health care
• Inpatient psychiatric treatment
• Electroconvulsive therapy
• Psychiatric rehabilitation

Headquarters

HQ city

Mitaka

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Services Revenue: Revenue generated from psychiatric medical services including outpatient consultations, inpatient hospitalization, emergency psychiatric care, rehabilitation services, dental services, and visiting medical care. Services are covered under Japan's national health insurance system.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels2 records

Core offering

Aoikai Medical operates Hasegawa Hospital, a psychiatric and mental health facility in Mitaka City, Tokyo, providing outpatient psychiatric consultations, inpatient psychiatric hospitalization with emergency and acute-phase care, modified Electroconvulsive Therapy (mECT) for treatment-resistant conditions, psychiatric and physical rehabilitation, day care programs, visiting medical and nursing services, dental care, and on-site pharmacy services under Japan's national health insurance system.

Product overview

Aoikai Medical operates through Hasegawa Hospital, a psychiatric and medical facility offering a comprehensive range of healthcare services. The hospital provides outpatient and inpatient psychiatric care, emergency psychiatric services, specialized treatments including modified electroconvulsive therapy (mECT), rehabilitation services (both psychiatric and physical), home healthcare visits, dental care, and pharmacy services. The hospital also offers day care programs and regional medical coordination services. As part of the Aoikai Group (葵会グループ), the facility focuses on psychiatric care with acute treatment capabilities and rehabilitation programs for inpatients and outpatients.

Differentiator

Problem solved

Functional benefit

Products and services

• Outpatient Psychiatric Consultation (精神科外来診療) Outpatient psychiatric consultations offered Monday through Saturday mornings and on Monday, Tuesday, Thursday, and Friday afternoons for patients seeking non-hospitalized psychiatric assessment and follow-up care.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Aoikai Group (葵会グループ)coreOthersHasegawa Hospital operates as part of the Aoikai (葵会) Group, a psychiatric medical corporation. The group includes multiple psychiatric facilities: Aoi Mental Hospital (aoimental), Nogawa Home (nogawahome), and rehabilitation centers. Group facilities provide mutual referral pathways and shared resources.

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Direct peers

• Aoi Mental Hospital (葵会グループ): Sibling psychiatric facility within the same Aoikai Group operating acute and chronic psychiatric inpatient services in the Tokyo area. Operates under an identical corporate parent (Seiseikai Medical Corporation / Aoikai Group), shared clinical protocols, and mutual referral pathways with Hasegawa Hospital.
• Komagino Hospital (駒木野病院): Established Tokyo-area psychiatric hospital offering inpatient psychiatric care, emergency psychiatry, and rehabilitation. Directly comparable to Hasegawa Hospital in scope of psychiatric services, patient population, and operating model under the Japanese national health insurance system.
• Asakayama Hospital (朝山病院): Japanese psychiatric hospital providing acute, chronic, and rehabilitation psychiatric inpatient services in the greater Tokyo/Kanto region. Comparable in scale, service breadth, and reliance on Japan's national health insurance reimbursement.

Regional players

• Psychiatric Care Holdings (Japan psychiatric hospital chains): Collective reference for Japanese multi-facility psychiatric hospital operators outside the Aoikai Group. These chains offer similar inpatient psychiatric, emergency, and rehabilitation services under Japan's national insurance system and represent direct competitive pressure within regional Japanese psychiatric markets.

Broad incumbents

• Universal Health Services (UHS): Major US hospital operator with a significant behavioral health segment running acute psychiatric inpatient hospitals. Comparable at the business-model level as a multi-site psychiatric hospital operator, though operating in a private-pay-leaning US market versus Japan's national-insurance system.
• HCA Healthcare: Largest US for-profit hospital operator with behavioral health service lines. Useful as a broad incumbent reference for how integrated hospital systems deliver psychiatric services alongside other medical specialties, though at vastly different scale and in a different reimbursement environment.
• Acadia Healthcare: Large US-listed operator of psychiatric inpatient facilities and behavioral health treatment programs. While geographically separate and at much greater scale, it operates an analogous inpatient psychiatric hospital business model and is a useful benchmark for facility-level psychiatric care economics.
• National Center of Neurology and Psychiatry (NCNP): Japan's national center for neurology and psychiatry, providing advanced psychiatric inpatient and outpatient care alongside research. While much larger and research-focused, it is a leading reference facility for treatment-resistant psychiatric conditions in the same Tokyo market as Aoikai Medical.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aoikai Medical